J0736 HCPCS Level II Code: Injection, clindamycin phosphate, 300 mg
Medicare Coverage & Payment
- CMS short descriptor: Inj, clindamycin phosp 300mg
- Medicare coverage: Carrier judgment (CMS coverage code C)
- Payment category: Drugs (pricing indicator 51)
- BETOS: O1E — Other drugs
- Last CMS action effective: January 1, 2024
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Change history
- July 1, 2023Added to the code setInjection, clindamycin phosphate, 300 mg
Drug products (NDC)
CMS ASP NDC-HCPCS Crosswalk · 2026 Q3
Medicare Part B payment limit (ASP + 6%): $1.97
00009-0728-09 Cleocin — Pfizer Inc (size 60 × qty 5 (300 MG per billing unit))
00009-0775-26 Cleocin — Pfizer Inc (size 4 × qty 25 (300 MG per billing unit))
00009-0870-26 Cleocin — Pfizer Inc (size 2 × qty 25 (300 MG per billing unit))
00009-0902-18 Cleocin — Pfizer Inc (size 6 × qty 25 (300 MG per billing unit))
00009-3051-02 Cleocin — Pfizer Inc (size 2 × qty 25 (300 MG per billing unit))
00009-4073-04 Cleocin — Pfizer Inc (size 4 × qty 25 (300 MG per billing unit))
00009-5095-06 Cleocin — Pfizer Inc (size 6 × qty 25 (300 MG per billing unit))
00404-9837-02 Cleocin — Henry Schein Inc. (size 2 × qty 1 (300 MG per billing unit))
00404-9838-04 Clindamycin Phosphate — Henry Schein Inc. (size 4 × qty 1 (300 MG per billing unit))
00781-3288-09 Clindamycin Phosphate — Sandoz Inc. (size 50 × qty 24 (300 MG per billing unit))
00781-3289-09 Clindamycin Phosphate — Sandoz Inc. (size 50 × qty 24 (300 MG per billing unit))
00781-3290-09 Clindamycin Phosphate — Sandoz Inc. (size 50 × qty 24 (300 MG per billing unit))
+7 more
Related Codes
Same drug, other billing codes
CMS's ASP crosswalk lists these HCPCS codes for the same drug.
J0737 — Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.
Contextual Map
Every relationship of J0736 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (34)
- J0701 — Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg[Sibling]
- J0702 — Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg[Sibling]
- J0703 — Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg[Sibling]
- J0706 — Injection, caffeine citrate, 5 mg[Sibling]
- J0710 — Injection, cephapirin sodium, up to 1 gm[Sibling]
- J0712 — Injection, ceftaroline fosamil, 10 mg[Sibling]
- J0713 — Injection, ceftazidime, per 500 mg[Sibling]
- J0714 — Injection, ceftazidime and avibactam, 0.5 g/0.125 g[Sibling]
- and 26 more
Change history
- July 1, 2023 — Added to the code set [Change history]
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J0736 in its code family, with their registry titles.
- J0716 — Injection, centruroides immune f(ab)2, up to 120 milligrams
- J0717 — Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0720 — Injection, chloramphenicol sodium succinate, up to 1 gm
- J0725 — Injection, chorionic gonadotropin, per 1,000 usp units
- J0735 — Injection, clonidine hydrochloride, 1 mg
- J0737 — Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
- J0738 — Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0739 — Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0740 — Injection, cidofovir, 375 mg
- J0741 — Injection, cabotegravir and rilpivirine, 2mg/3mg